Monoclonal Mouse anti‑Human EPHA8 / EPH Receptor A8 Antibody (clone 9A12D8, Amino Acid: 70‑150, WB) LS‑C758552
Monoclonal Mouse anti‑Human EPHA8 / EPH Receptor A8 Antibody (clone 9A12D8, Amino Acid: 70‑150, WB) LS‑C758552
Antibody:
EPHA8 / EPH Receptor A8 Mouse anti-Human Monoclonal (Amino Acid: 70-150) (9A12D8) Antibody
Format:
Unconjugated, Unmodified
Overview
Antibody:
EPHA8 / EPH Receptor A8 Mouse anti-Human Monoclonal (Amino Acid: 70-150) (9A12D8) Antibody
Format:
Unconjugated, Unmodified
Specifications
Description
EPH Receptor A8 antibody LS-C758552 is an unconjugated mouse monoclonal antibody to human EPH Receptor A8 (EPHA8) (Amino Acid: 70-150). Validated for WB.
Target
Human EPHA8 / EPH Receptor A8
Synonyms
EPHA8 | EEK | EPH- and ELK-related kinase | EK3 | EPH receptor A8 | EPH-like kinase 3 | Ephrin type-A receptor 8 | HEK3 | Hydroxyaryl-protein kinase | KIAA1459 | Tyrosylprotein kinase | Hek3 kinase | Protein-tyrosine kinase
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG1
Monoclonal
Conjugations
Unconjugated
Immunogen
Purified recombinant fragment of EphA8 (aa70-150) expressed in E. coli.
Epitope
Amino Acid: 70-150
Applications
- Western blot (1:500 - 1:2000)
Usage
Applications should be user optimized.
Presentation
Ascites, 0.03% sodium azide
Storage
Short term: 4°C; Long term: -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About EPHA8 / EPH Receptor A8
Featured Products
Species:
Human, Mouse
Applications:
Western blot
Reactivity:
Human
Range:
0.16-10 ng/ml
Reactivity:
Rat
Range:
0.156-10 ng/ml
Species:
Human, Mouse
Applications:
IHC, IHC - Paraffin, Western blot
Species:
Mouse
Applications:
Western blot
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot, ELISA
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/27/2024